Form 4: Aspen Aerogels Director William P. Noglows Receives Stock Options and Restricted Shares

Director William P. Noglows acquired stock options and restricted shares of Aspen Aerogels as part of the annual equity grant for non-employee directors.

Summary

• On May 30, 2024, William P. Noglows, a director of Aspen Aerogels, Inc., was granted 1,898 restricted shares of common stock.
• These shares are part of the annual equity grant for non-employee directors and will vest on the earlier of May 30, 2025, or the day before the 2025 annual meeting of stockholders.
• Noglows also received options to purchase 1,657 shares of common stock at an exercise price of $29.50, which also vest on the earlier of May 30, 2025, or the day before the 2025 annual meeting.
• Following these transactions, Noglows directly owns 78,617 shares of Aspen Aerogels common stock.
• Additionally, he indirectly owns 10,000 shares through a trust for one child and another 10,000 shares through a trust for another child.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (equity grant) and doesn't contain any alarming or negative information. It's a standard practice, hence a neutral to slightly positive sentiment.

Positives

• The grant of restricted shares and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements, but the equity grants suggest an expectation of continued service from the director.

Industry Context

Equity grants to non-employee directors are a common practice in publicly traded companies to incentivize and retain board members.

Comparison to Industry Standards

• Equity compensation for non-employee directors varies widely based on company size, industry, and performance.
• Comparable companies in the materials science or manufacturing sectors, such as Cabot Corporation or Rogers Corporation, also utilize stock options and restricted stock units as part of their director compensation packages.
• The specific value of the grant would need to be compared against peer companies to determine if it is above, below, or in line with industry standards.

Stakeholder Impact

• The equity grants align the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The grants have a minor dilutive effect on existing shareholders.

Key Dates